Genetic of Skeletal Muscle Insulin Resistance
Part of paid clinical trials in San Antonio, Texas.
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study ID
- NCT07780513
- Status
- Recruiting
Conditions
- Insulin Stimulated
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Insulin 80mU/m2*min — OTHER80mU/m2\*min euglycemic-hyperinsulinemic clamp
Study Details
In this study, we will use euglycemic/hyperinsulinemic clamps, longitudinal skeletal muscle biopsies, and single nucleus RNA- and ATAC- sequencing to reveal cell type-specific molecular response Quantitative trait loci (rQTLs) acutely regulated by insulin signaling and glucose uptake.
Key Dates
- First listed
- Aug 21, 2026
- Start date
- Aug 31, 2026
- Status verified
- Aug 2026
- Primary completion
- Jul 31, 2031
- Completion
- Jul 31, 2031
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Insulin stimulated80mU/m2\*min euglycemic/hyperinsulinemic clamp
Primary Outcome Measure
Cell type specific quantitative trait loci in skeletal muscle [ Time Frame: Before and after insulin clamp ( Baseline to approximately 6 hours) ]
Central Contacts
- Luke Norton, Ph.D210-567-0739
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Texas Diabetes Institute - University Health System, San Antonio, Texas 78207 | San Antonio | Texas | 78229 | Luke Norton, Ph.D (PRINCIPAL_INVESTIGATOR) |